Nivagen Pharmaceuticals Inc
Manufacturer Details
There are currently no manufacturer details available.
Nivagen Pharmaceuticals Inc Drugs
-
![Pain Relief Pm (Acetaminophen, Diphenhydramine Hydrochloride) Liquid [Family Dollar, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=acd020d4-8dcf-403d-a8b4-06fb6e67d8b5&name=nivafol-01.jpg)
Pain Relief Pm
One to two tablets daily or as directed by a licensed medical practitioner.
-
![Niva-plus (Folic Acid, Vitamin A, Ascorbic Acid, Calcium Sulfate, Ferrous Fumarate, Cholecalciferol, .alpha.-tocopherol Acetate, Dl-, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Cyanocobalamin, Zinc Oxide, And Cupric Oxide) Tablet, Coated [Nivagen Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=58754e85-0104-44ec-bb0a-acc64677e329&name=niva-plus-01.jpg)
Niva-plus
Before, during and after pregnancy, one tablet daily, or as prescribed by a physician.
-
![Nivanex Dmx (Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride) Tablet [Nivagen Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9493e845-1b83-42c5-a7b5-ff3f3232e794&name=nivanex-01.jpg)
Nivanex Dmx
Do not exceed recommended dosage.
Adults and children 12 years of age and over 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours. Children 6 to under 12 years of age 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours. Children under 6 years of age Consult a physician. -
![Niva-hist Dm (Brompheniramine Maleate, Phenylephrine Hydrochloride, And Dextromethorphan Hydrobromide) Liquid [Nivagen Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ff0860ca-0c2b-4311-b903-bcfdb8604f1d&name=niva-hist-01.jpg)
Niva-hist Dm
Do not exceed recommended dosage.
Adults and children 12 years of age and over: 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonfuls in 24 hours Children 6 to under 12 years of age: 1/2 teaspoonful (2.5 mL) every 4 to 6 hours, not to exceed 3 teaspoonfuls in 24 hours Children under 6 years of age: Consult a doctor. -
![Metformin Hydrochloride Er (Metformin Hydrochloride) Tablet, Extended Release [Nivagen Pharmaceuticals Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d01b63e6-70e5-4679-b377-1e0fb78a87b5&name=d01b63e6-70e5-4679-b377-1e0fb78a87b5-02.jpg)
Metformin Hydrochloride Er
There is no fixed dosage regimen for the management of hyperglycemia in patients with type 2 diabetes with metformin hydrochloride extended release tablets USP or any other pharmacologic agent. Dosage of metformin hydrochloride extended release tablets USP must be individualized on the basis of both effectiveness and tolerance, while not exceeding the maximum recommended daily doses. The maximum recommended daily dose of metformin hydrochloride extended release tablets USP in adults is 2000 mg.
Metformin hydrochloride extended release tablets USP should generally be given once daily with the evening meal. Metformin hydrochloride extended release tablets USP should be started at a low dose, with gradual dose escalation, both to reduce gastrointestinal side effects and to permit identification of the minimum dose required for adequate glycemic control of the patient.
During treatment initiation and dose titration (see Recommended Dosing Schedule), fasting plasma glucose should be used to determine the therapeutic response to metformin hydrochloride extended release tablets USP and identify the minimum effective dose for the patient. Thereafter, glycosylated hemoglobin should be measured at intervals of approximately three months. The therapeutic goal should be to decrease both fasting plasma glucose and glycosylated hemoglobin levels to normal or near normal by using the lowest effective dose of metformin hydrochloride extended release tablets USP, either when used as monotherapy or in combination with sulfonylurea or insulin.
Monitoring of blood glucose and glycosylated hemoglobin will also permit detection of primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication, and secondary failure, i.e., loss of an adequate blood glucose lowering response after an initial period of effectiveness.
Short-term administration of metformin hydrochloride extended release tablets USP may be sufficient during periods of transient loss of control in patients usually well-controlled on diet alone.
Metformin hydrochloride extended release tablets USP must be swallowed whole and never crushed or chewed. Occasionally, the inactive ingredients of metformin hydrochloride extended release tablets USP will be eliminated in the feces as a soft, hydrated mass. (See Patient Information printed below.)
Sign Up for a Free Account